PUFAs (especially EPA/DHA), lipoxins, resolvins, protectins and maresins inhibit IL-23 and IL-17 and hence are expected to prevent salt and HFD and carbohydrate-induced HTN and T2DM (see Fig. 4). The gene discussed is IL17A; the disease is type 2 diabetes mellitus.